Helius Medical Technologies (HSDT)
(Delayed Data from NSDQ)
$6.10 USD
-0.81 (-11.72%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $6.13 +0.03 (0.49%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
HSDT 6.10 -0.81(-11.72%)
Will HSDT be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HSDT based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for HSDT
12 Health Care Stocks Moving In Monday's Pre-Market Session
Helius Medical Technologies (HSDT) PoNS Therapy Shows Promising Stroke Trial Results | HSDT ...
Helius Medical announces outcome of PoNS Stroke Registrational Program
Helius Medical (HSDT) Reaffirms Compliance with Nasdaq Listing Rules | HSDT Stock News
Helius Medical Technologies, Inc. Compliant with Nasdaq's Continued Listing Requirements | HSDT ...